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328a Monday, February 17, 2014exacerbated by elevated temperature. In summary, these results suggest tem-
perature fluctuations could be a trigger for long-QT and Brugada related
arrhythmias.
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Voltage gated sodium channels are membrane proteins that play a critical role
in electrical signaling of excitable cells. Amongst this family, the isoform
Nav1.5 is responsible for the initiation and propagation of cardiac action poten-
tials. As most of membrane proteins, Nav1.5 is well known to be a glycoprotein
with ~5% of its total weight corresponding to carbohydrates. To date, it has
been shown that Nav1.5 glycosylations such as sialylations influence biophys-
ical properties of this channel protein. However, whereas N-glycosylation are
well known post-traductional modifications that modulate surface localization
of many ionic channels, little is known about these maturation impacts on
voltage gated sodium channels. Perturbation of Nav1.5 trafficking is a well
characterized phenomenon occurring in pathology such as Brugada syndrome.
Our laboratory previously revealed that trafficking defective mutants of Nav1.5
exert a dominant negative effect upon wild type protein surface localization.
The objective of this study was (i) to characterize N-glycosylations of
Nav1.5 during its membrane trafficking and (ii) to investigate these maturations
in the context of the dominant negative effect exerted by Nav1.5 trafficking
defective mutations.
1664-Pos Board B394
Selective Inhibition of Late NaD Current Reduces Arrhythmic Activity in
Spontaneously Hypertensive Rat Myocytes
Nesrine El-Bizri, Steven Nguyen, Gongxin Liu, Luiz Belardinelli,
Sridharan Rajamani.
Gilead Sciences, Fremont, CA, USA.
The cardiac late Naþ current (INaL) is enhanced in hypertrophy, heart failure
and ischemia. Spontaneously hypertensive rats (SHR) are characterized by
prolonged action potential duration (APD), [Naþ]i and [Ca
2þ]i overload and
triggered activity (TA). We hypothesized that INaL is enhanced in SHR and
contribute to APD prolongation and TA. INaL was increased in ventricular my-
ocytes isolated from 10- to 12-month-old SHR (0.8450.13 pA/pF, n ¼ 16)
compared to age-matched Wistar rats (WR; 0.2650.06 pA/pF, n ¼ 9; p <
0.01). INaL inhibitors ranolazine (RAN) and GS-458967 (GS967) reduced
INaL in myocytes from SHR with IC50 of 3.750.1 and 0.6550.04 mM;
respectively. APD70 and APD90 were prolonged in myocytes from SHR,
compared to WR, and were shortened by RAN (10 mM) and GS967 (1 mM)
(Table). In 8/23myocytes from SHR, spontaneous delayed afterpotentials
(DADs) and/or TA were observed. Pacing induced DADs in 8/10 and TA
in 4/10 myocytes from SHR. GS967 (1 mM) abolished both spontaneous
and pacing induced TA (4/4).Our data
show that INaL is enhanced and contributes
to APD prolongation and TA in myocytes
from SHR. Selective inhibition of INaL
could stabilize cardiac repolarization and
suppress arrhythmias in hypertension.1665-Pos Board B395
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The late Naþ current (INa,L) is known to contribute to cardiac action potential
(AP) plateau and upregulation of INaL leads to arrhythmogenic activities. We
used an innovative self-action potential (sAP)-clamp technique to directly re-
cord the dynamic INa,L during the cell’s own AP. We studied the dynamic
INaL in rabbit ventricular myocytes under physiological conditions wherein
[Naþ]i and [Ca2þ]i homeostasis were preserved. We then determined the ef-
fect of GS967, a newly developed selective and potent inhibitor of INa,L. Re-
sults: (1) During the various phases of AP waveform, the dynamic INa,L
amplitude was low at phase-1, gradually increased during phase-2 to reach
a peak, and declined at phase-3. This profile of INa,L magnitude and time
course under AP-clamp is distinctively different from the monotonically
declining INa,L current seen under rectangular pulse voltage-clamp due to
non-equilibrium gating. (2) GS967 selectively inhibits INa,L during AP in a
concentration-dependent manner with an IC50 of 57 nM. Unlike tetrodotoxin,
GS967 did not significantly inhibit the fast Naþ current. Hence, GS967 short-ened the AP duration without affecting the AP upstroke. (3) The INa,L peak
amplitude was 0.7850.07 A/F under physiological condition. Anemonia
toxin II (ATX-II) at 5 nM increased the INaL amplitude to 1.25 50.14 A/
F, and prolonged APD95 from 212.4510.5 ms (control) to 305.6519.1 ms
(ATX-II). GS967 (1uM) effectively shortened APD and suppressed afterdepo-
larizations (EADs) induced by ATX-II. Conclusion: Our sAP-clamp data
reveal a surprisingly large INa,L during AP plateau under physiological con-
dition, which explains why INa,L significantly affect cardiac AP morphology
and arrhythmogenesis. GS967 inhibits INa,L during AP plateau without
blocking the fast Naþ current at AP upstroke, and therefore provides a prom-
ising therapeutic strategy to suppress cardiac arrhythmias without slowing
conduction.
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Nociceptive sensory neurons transmit painful stimuli from the periphery to the
central nervous system. Voltage-gated sodium (NaV) channels are instrumental
for the generation of the corresponding electrical signals, but - so far - the sen-
sory neuron-specific NaV1.9 only appeared to play a minor role. Recently, we
identified a de novo heterozygous mutation in the SCN11A gene encoding for
NaV1.9 and demonstrated the implication of NaV1.9 in human pain perception
(Leipold et al., Nature Genetics, DOI 10.1038/ng.2767). Surprisingly, in
affected individuals the mutation (L811P) leads to an inability to experience
pain by conferring gain-of-function (GOF) properties to NaV1.9. Mutant chan-
nels activate at hyperpolarized voltages and display a slow-down of channel
inactivation and deactivation, thereby causing sustained depolarization of noci-
ceptor cells and alterations of action potential characteristics. This new chan-
nelopathy is different from other pain-related NaV channel disorders: a GOF
of homologous NaV1.7 channels is associated with chronic pain, and loss of
functional NaV1.7 channels causes congenital indifference to pain. To gain
further insight into the mechanisms underlying the mutation we introduced
the homologous L-to-P mutation into channel isoforms NaV1.4 (L802P),
NaV1.7 (L957P) and NaV1.8 (L890P) and compared the functional parameters
of wild-type and mutant channels by means of the whole-cell patch-clamp tech-
nique. The L-to-P mutation shifted the activation in all channel subtypes to hy-
perpolarized potentials in the order NaV1.9 > NaV1.7 > NaV1.4 > NaV1.8.
Fast channel inactivation was slowed down most prominently in NaV1.9 and
NaV1.8, followed by NaV1.7 and NaV1.4. These results show that a homolo-
gous L-to-P mutation affects channel activation and inactivation in a subtype-
specific manner.
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Human mortality associated with status epilepticus (SE) in U.S and Canada is
21%-22%. Sudden death caused by epilepsy (SUDEP) accounts for 17% of all
SE-related casualties. Clinical evidence linked SUDEP to arrhythmias such as
conduction block and prolongation of the QT interval, an index of repolariza-
tion time, on the cardiac electrocardiogram. These observations suggest that
SE altered the activity of the cardiac sodium current (INa) involved in both
cardiac conduction and repolarization of the ventricle. We tested this hypoth-
esis by characterizing INa in ventricular cardiomyocytes of epileptic rats
induced induced by kainic acid injection. Our patch clamp results show that
epilepsy increased peak INa by 1856% and its sustained (late) component
(INaL) by 53513%. Activation of INa occurred at more negative potential in
epileptic rats and recovery from activation was significantly delayed by epi-
lepsy. Because epilepsy is known to increase the expression of neuronal chan-
nels (nNaVs) in the brain we next tested if the changes in INa were associated
with increased sensitivity to tetrodotoxin (TTX), a hallmark of nNaVs. Our
results indicate that TTX at a concentrations not affecting the cardiac sodium
channel NaV1.5 (1 nM) blocked 34% and 50% of INaL in Sham and epileptic
rats respectively. Epilepsy therefore increased the contribution of neuronal so-
dium channel to INa in the cardiac ventricle. In summary, our data indicate
that epilepsy altered INa in a manner consistent with the alterations of
